Scaglione, Vincenzo
Rotundo, Salvatore
Marascio, Nadia
De Marco, Carmela
Lionello, Rosaria
Veneziano, Claudia
Berardelli, Lavinia
Quirino, Angela
Olivadese, Vincenzo
Serapide, Francesca
Tassone, Bruno
Morrone, Helen Linda
Davoli, Chiara
La Gamba, Valentina
Bruni, Andrea
Cesana, Bruno Mario
Matera, Giovanni
Russo, Alessandro
Costanzo, Francesco Saverio
Viglietto, Giuseppe
Trecarichi, Enrico Maria
Torti, Carlo https://orcid.org/0000-0001-7631-5453
,
Trecarichi, Enrico Maria
Russo, Alessandro
Serapide, Francesca
Tassone, Bruno
Fusco, Paolo
Scaglione, Vincenzo
Davoli, Chiara
Lionello, Rosaria
Gamba, Valentina La
Rotundo, Salvatore
Morrone, Helen
Berardelli, Lavinia
Tassone, Maria Teresa
Olivadese, Vincenzo
Serraino, Riccardo
Costa, Chiara
Alcaro, Stefano
Filippo, Caterina De
Sarro, Giovambattista De
Pujia, Arturo
Quattrone, Aldo
Costanzo, Francesco Saverio
Cuda, Giovanni
Foti, Daniela Patrizia
Viglietto, Giuseppe
Matera, Giovanni
Longhini, Federico
Bruni, Andrea
Garofalo, Eugenio
Biamonte, Eugenio
Brescia, Vincenzo
Laganà, Domenico
Petullà, Maria
Bertucci, Bernardo
Quirino, Angela
Barreca, Giorgio Settimo
Giancotti, Aida
Gallo, Luigia
Lamberti, Angelo
Marascio, Nadia
Francesco, Adele Emanuela De
Mirarchi, Simona
Torti, Carlo https://orcid.org/0000-0001-7631-5453
Funding for this research was provided by:
Regione Calabria (FESR/FSE 2014-2020 DDRC n. 4585, Action 10.5.12, noCOVID19@UMG)
Article History
Received: 20 July 2022
Accepted: 9 October 2022
First Online: 20 October 2022
Change Date: 24 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12879-022-07871-9
Declarations
:
: This study was conducted using retrospectively collected anonymized data and performed in accordance with the Declaration of Helsinki and principles of good clinical practice (World Medical Association 2013). This retrospective analysis was notified to the Ethics Committee of the Calabria region on May 13, 2020. The need for written informed consent was waived for patients owing to the retrospective nature of the study. In Italy, such studies do not require ethical approval by an Ethics Committee as determined by as determined by the Italian Drug Agency note 20 March 2008 (GU Serie Generale no. 76 31/3/2008). For patients entering the study from January 20, 2022, the study was approved by the Ethics Committee of the Calabria region (protocol reference n. 21, FESR/FSE 2014–2020 DDRC n. 4585, Action 10.5.12, noCOVID19@UMG). Patients enrolled in this part of the study signed an informed consent.
: The patients described in the case series gave written consent for their data to be published.
: None to disclose.